Spectral AI announced continuing progress in the development of DeepView SnapShot M, a handheld diagnostic tool targeted for use in battlefield burn assessment that is based on the Company’s AI-driven DeepView System platform. “Successful burn wound management is essential to patient survival, and this need is magnified in the battlefield setting,” said Peter M. Carlson, Chief Executive Officer of Spectral AI. “Developing technology that can support our nation’s armed forces is a matter of much personal and professional pride for all of us at Spectral AI, and we are honored to be a part of a select group of companies pursuing that objective. We are continuing to advance the evolution of this proprietary AI-driven burn wound assessment technology, and believe that its potential applications can extend beyond military use to serve our first responders and other healthcare providers.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDAI:
- Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
- Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
- Spectral AI announces total U.S, international portfolio has 26 granted patents
- Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System
- Spectral adds three new clinical trial sites to expedite ED patient enrollment